tirzepatide is insulin or not outcompetes long-acting in managing type 2 diabetes: a meta-analysis of three phase 3 randomized controlled trials Mounjaro vs. Insulin: Which Is

Ensuring equitable access and strengthening health systems will be essential to prevent widening health disparities.AgendaCo-chairsDr Luz de Regil Director, Department of Nutrition and Food Safety, WHO and Dr Kirsten Bibbins Domingo Editor-in-Chief, JAMAModeratorDr Gaya Manori Gamhewage, Director, Department of Communication, WHOWelcomingDr Luz De Regil Director NFS, WHO and Dr Kirsten Bibbins-Domingo, Editor-in-Chief, JAMAPresentation:WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adultsDr Francesca Celletti, Senior Advisor Obesity, Department of Nutrition and Food Safety, WHO and Dr

While many associate GLP-1 with popular diabetes or weight loss medications, few understand the powerful role this naturally occurring hormone plays

Two medications that have gained attention for their potential in weight loss are semaglutide and topiramate.

Learn key differences in dosing, weight loss results, half-life, side effects, and which GLP-1 fits best.